Last kr233.60 DKK
Change Today +2.00 / 0.86%
Volume 408.8K
CHR On Other Exchanges
Symbol
Exchange
Copenhagen
Frankfurt
OTC US
OTC US
As of 11:03 AM 04/16/14 All times are local (Market data is delayed by at least 15 minutes).

chr hansen holding a/s (CHR) Snapshot

Open
kr232.10
Previous Close
kr231.60
Day High
kr234.90
Day Low
kr232.10
52 Week High
04/9/14 - kr235.00
52 Week Low
08/19/13 - kr180.15
Market Cap
31.4B
Average Volume 10 Days
633.5K
EPS TTM
kr1.08
Shares Outstanding
134.5M
EX-Date
11/27/13
P/E TM
29.1x
Dividend
kr3.13
Dividend Yield
2.68%
Current Stock Chart for CHR HANSEN HOLDING A/S (CHR)

Related News

No related news articles were found.

chr hansen holding a/s (CHR) Related Businessweek News

No Related Businessweek News Found

chr hansen holding a/s (CHR) Details

Chr. Hansen Holding A/S, a bioscience company, develops, produces, and sells natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries. The company’s Cultures and Enzymes division produces cultures, enzymes, and probiotic products that determine the taste, flavor, color, texture, safety, preservation, nutritional value, and health benefits of various consumer products in the food and dairy industries. Its Health and Nutrition division provides probiotic cultures for the dietary supplement, over-the-counter pharmaceutical, infant formula, and animal feed industries. Its Natural Colors division offers natural color solutions for the food and beverage industries, primarily the beverage, confectionery, ice cream, dairy, and fruit preparation segments. The company has strategic alliance with FMC Corporation for development and commercialization of biological crop protection products. Chr. Hansen Holding A/S operates in Europe, the Middle East, Africa, North and South America, and the Asia Pacific. Chr. Hansen Holding A/S was founded in 1874 and is headquartered in Hørsholm, Denmark.

2,500 Employees
Last Reported Date: 04/9/14
Founded in 1874

chr hansen holding a/s (CHR) Top Compensated Officers

Chief Executive Officer and Member of Executi...
Total Annual Compensation: €250.0K
Chief Financial Officer and Member of Executi...
Total Annual Compensation: €560.0K
Executive Vice President of Cultures & Enzyme...
Total Annual Compensation: €570.0K
Executive Vice President of Natural Colors Di...
Total Annual Compensation: €480.0K
Executive Vice President of Stakeholder Relat...
Total Annual Compensation: €390.0K
Compensation as of Fiscal Year 2013.

chr hansen holding a/s (CHR) Key Developments

Chr. Hansen Holding A/S Reports Unaudited Earnings Results for the Second Quarter and Year to Date February 28, 2014; Reaffirms Earnings Guidance for the Year 2014

Chr. Hansen Holding A/S reported unaudited earnings results for the second quarter and year to date February 28, 2014. For the quarter, the company reported revenue of EUR 181.5 million compared to EUR 174.4 million a year ago. Operating profit was EUR 41.6 million compared to EUR 32.6 million a year ago. Profit before tax was EUR 37.1 million compared to EUR 28.5 million a year ago. Profit attributable to shareholders of the company was EUR 27.1 million compared to EUR 20.2 million a year ago. Basic and diluted earnings per share from continuing operations was EUR 0.20 compared to EUR 0.15 a year ago. Cash flow from operating activities was EUR 45.1 million compared to EUR 49.1 million a year ago. Investments in intangible assets were EUR 2.6 million compared to EUR 4.1 million a year ago. Investments in property, plant and equipment was EUR 10.2 million compared to EUR 12.3 million a year ago. EBITDA was EUR 57.9 million compared to EUR 52.6 million a year ago. EBIT before special items was EUR 45.0 million compared to EUR 32.6 million a year ago. For the year to date, the company reported revenue of EUR 352.8 million compared to EUR 352.9 million a year ago. Operating profit was EUR 84.1 million compared to EUR 80.2 million a year ago. Profit before tax was EUR 77.1 million compared to EUR 72.4 million a year ago. Profit attributable to shareholders of the company was EUR 56.2 million compared to EUR 52.0 million a year ago. Basic and diluted earnings per share from continuing operations was EUR 0.42 compared to EUR 0.39 a year ago. Cash flow from operating activities was EUR 27.5 million compared to EUR 36.3 million a year ago. Investments in intangible assets were EUR 7.0 million compared to EUR 9.9 million a year ago. Investments in property, plant and equipment was EUR 19.3 million compared to EUR 20.4 million a year ago. EBITDA was EUR 113.7 million compared to EUR 111.7 million a year ago. EBIT before special items was EUR 88.1 million compared to EUR 80.2 million a year ago. Net interest bearings debt at February 28, 2014 was EUR 445.6 million against EUR 446.1 million at February 28, 2013. The company reaffirmed its earnings guidance for the year 2014. For the year, the company expects, organic revenue growth to be 7-9%. Research & development expenditures incurred as a percentage of revenue are expected to move toward 7% of revenue from 6.1% in 2012/13. Chr. Hansen has reassessed the capitalization of development expenditures. Based on this reassessment a higher proportion of development expenditures is expected to be expensed in 2013/14. The increased research & development activity and lower level of capitalization are estimated to reduce the EBIT margin by 1-1.5 percentage points. The EBIT margin before special items is expected to be above 26%.

Chr. Hansen A/S Opens New Office and Global Expertise Center in Shanghai

Chr. Hansen A/S has opened a new office and global expertise center in the Changning district of Shanghai. The new center focusing on natural color solutions. The new Shanghai Global Expertise Center will enable the company to provide a better service and inspiration to valued Chinese customers.

Chr. Hansen Holding A/S, Q2 2014 Earnings Call, Apr 09, 2014

Chr. Hansen Holding A/S, Q2 2014 Earnings Call, Apr 09, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CHR:DC kr233.60 DKK +2.00

CHR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Balchem Corp $62.96 USD +0.33
Corbion NV €16.79 EUR +0.28
Ebro Foods SA €15.99 EUR -0.16
Greencore Group PLC 254.40 GBp -5.00
Koninklijke Wessanen NV €4.01 EUR -0.019
View Industry Companies
 

Industry Analysis

CHR

Industry Average

Valuation CHR Industry Range
Price/Earnings 29.3x
Price/Sales 5.7x
Price/Book 6.7x
Price/Cash Flow 29.7x
TEV/Sales 5.0x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHR HANSEN HOLDING A/S, please visit www.chr-hansen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.